Alnylam Pharmaceuticals saw the highest growth of 0.96% in patent filings in May and 1.32% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.91% and grants by 1.32%. GlobalData’s DataBook provides a comprehensive analysis of Alnylam Pharmaceuticals‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Alnylam Pharmaceuticals has been focused on protecting inventions in United States(US) with 37 publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 32% filings and 35% grants. The United States(US), European Patent Office(EPO), Australia(AU), and Israel(IL) patent Office are among the top ten patent offices where Alnylam Pharmaceuticals is filings its patents. Among the top granted patent authorities, Alnylam Pharmaceuticals has 35% of its grants in United States(US), 13% in Australia(AU) and 13% in Israel(IL).
Arrowhead Pharmaceuticals and Novo Nordisk Foundation could be the strongest competitors for Alnylam Pharmaceuticals
Patents related to rare diseases and climate change lead Alnylam Pharmaceuticals's portfolio
Alnylam Pharmaceuticals has the highest number of patents in rare diseases followed by, climate change and nanomedicine. For rare diseases, nearly 75% of patents were filed and 59% of patents were granted in Q2 2024.
Alzheimer's disease related patents lead Alnylam Pharmaceuticals portfolio followed by hypertension, and kidney disease (nephropathy)
Alnylam Pharmaceuticals has highest number of patents in alzheimer's disease followed by hypertension, kidney disease (nephropathy), hyperlipidemia, and metabolic syndrome. For alzheimer's disease, nearly 5% of patents were filed and 5% of patents were granted in Q2 2024.
For comprehensive analysis of Alnylam Pharmaceuticals's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
